Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
People with depression can treat themselves at home with new device - 2The most effective method to Integrate Compact disc Rates into Your Retirement Arranging
- 3Figure out How to Get a good deal on Your Rooftop Substitution Venture
- 4FDA updates risk classification for voluntary shredded cheese recall
- 5Well known Tea Brands for Each Tea Sweetheart
- 35 million tons of food go to waste yearly in the US. Experts share tips to help stop it
- Novo Nordisk cuts Wegovy price as CEO pledges to go 'all in' on weight loss pill
- Instructions to Choose the Best Web based Advertising Degree Program for Your Objectives
- Investigate the Excellence of Professional flowerbeds: A Virtual Local escort
- Tatiana Schlossberg, a granddaughter of JFK, is dead at 35 after cancer diagnosis
- Argentina reportedly delaying embassy move over Israeli company's oil project near Falklands
- The Benefits of Rehearsing Careful Nurturing
- Hunger and makeshift shelters persist in north Caribbean nearly 2 months after Hurricane Melissa
- Understanding Various Sorts of Financial balances: An Extensive Outline
